Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeting Tumor Acidosis and Regulatory T Cells Unmasks Anti-Metastatic Potential of Local Tumor Ablation in Triple-Negative Breast Cancer

International Journal of Molecular Sciences(2022)10.3390/ijms23158479Source: DataRank Database

Targeting Tumor Acidosis and Regulatory T Cells Unmasks Anti-Metastatic Potential of Local Tumor Ablation in Triple-Negative Breast Cancer is a research paper published in International Journal of Molecular Sciences (2022). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.64)OA: goldTopics (52)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Alana Gonzales ORCID,Erika Chelales ORCID,Júlia Sroda Agudogo ORCID,Brian T. Crouch ORCID,Smita K. Nair ORCID

Live enrichment

PubMed:35955613 PMC:PMC9368760 OpenAlex:https://openalex.org/W4289175727

North Carolina Biotechnology Center Biotechnology Innovation

Grant: 1R21CA241205-01

North Carolina Biotechnology Center Biotechnology Innovation

Grant: 1R01CA239268-01

Novel see and treat strategies for cervical cancer prevention in low-resource settings

North Carolina Biotechnology Center

Grant: Biotechnology Innovation Grant

North Carolina Biotechnology Center Biotechnology Innovation

FWCI

0.64

Citation Percentile

0.6%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/1422-0067/23/15/8479/pdf?version=1659404032

publisherhttps://www.mdpi.com/1422-0067/23/15/8479/pdf?version=1659404032

publisherhttps://www.mdpi.com/1422-0067/23/15/8479/pdf

journalhttps://doi.org/10.3390/ijms23158479

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35955613

Fields of Study

Nanoplatforms for cancer theranosticsCancer Immunotherapy and BiomarkersCancer Research and Treatments0301 basic medicine03 medical and health sciences0302 clinical medicineAcidosisAnimalsCell Line, TumorCyclophosphamideHumansMiceMice, Inbred BALB CMice, Inbred C57BLT-Lymphocytes, RegulatoryTriple Negative Breast NeoplasmsTumor Microenvironment

MeSH Terms

AcidosisAnimalsCyclophosphamideHumansMice, Inbred BALB CMice, Inbred C57BLCell Line, TumorT-Lymphocytes, RegulatoryMiceTumor MicroenvironmentTriple Negative Breast Neoplasms

Keywords

Triple-negative breast cancerCancerMedicineAblationCancer researchBreast cancerAcidosisMetastatic tumorMetastasisInternal medicineOncologyImmunomodulationTumor MicroenvironmentLow-resourceMice, Inbred BALB CTriple Negative Breast NeoplasmsT-Lymphocytes, RegulatoryArticleMice, Inbred C57BLMiceCell Line, TumorAnimalsHumansCyclophosphamide

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being